Wallenberg syndrome (lateral medullary syndrome) is a distinct neurovascular brainstem syndrome resulting from ischemia of the lateral medulla oblongata, most commonly secondary to occlusion or dissection of the vertebral artery or the posterior inferior cerebellar artery (PICA)1, 2. First comprehensively detailed by Adolf Wallenberg in 1895, this syndrome manifests with an intricate constellation of ipsilateral and contralateral signs due to the unique spatial arrangement of ascending and descending tracts alongside cranial nerve nuclei in the lower brainstem1.

1. Etiology & Risk Factors

  • Vascular Occlusion: Atherothrombotic occlusion of the intracranial vertebral artery (its most common cause) or the posterior inferior cerebellar artery (PICA) branch1, 4.
  • Arterial Dissection: Spontaneous or traumatic dissection of the extracranial or intracranial vertebral artery, frequently seen in younger cohorts following sudden neck rotation or chiropractic manipulation6.
  • Cardioembolism: Embolic source originating from atrial fibrillation, mural thrombi, valvular heart disease, or paradoxical emboli via patent foramen ovale.
  • Traditional Cardiovascular Risk Factors: Essential hypertension (present in over 50% of cohorts), dyslipidemia, diabetes mellitus, smoking, and advanced age4.
  • Vertebrobasilar Dolichoectasia: Elongation, tortuosity, and widening of the vertebrobasilar arterial trunk leading to hemodynamic insufficiency or perforating branch ischemia.

2. Pathophysiology

The lateral medulla contains a compact aggregation of vital autonomic pathways, cerebellar connections, and sensory tracts. Ischemia within this territory disrupts specific anatomical structures: the spinothalamic tract causes contralateral trunk and limb thermoanesthesia; the spinal trigeminal nucleus and tract cause ipsilateral facial pain and temperature loss; the descending sympathetic fibers cause ipsilateral Horner syndrome; the inferior cerebellar peduncle results in ipsilateral limb and gait ataxia; and the nucleus ambiguus leads to ipsilateral palatal, pharyngeal, and laryngeal paralysis causing severe dysphagia and dysphonia1, 2.

Wallenberg syndrome (lateral medullary syndrome) — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Atherosclerotic occlusion, thromboembolism, or vertebral artery dissection in the vertebrobasilar system 2 Cellular / Pathophysiological Cascade Focal ischemia and cytotoxic edema within the posterolateral medulla oblongata 3 Target Organ / Structural Change Damage to cranial nerve nuclei, spinothalamic tracts, descending sympathetic fibers, and inferior cerebellar peduncle 4 Hallmark Clinical & Diagnostic Manifestation Ipsilateral Horner syndrome, facial sensory loss, ataxia, and contralateral body pain/temperature dissociation 5 Complications if Untreated & Therapeutic Target Aspiration pneumonia, severe dysphagia, respiratory compromise; managed with early NPO, neurorehabilitation, and secondary stroke prophylaxis

3. Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Sudden onset of severe rotational vertigo, nausea, vomiting, imbalance, unsteadiness, hoarseness, difficulty swallowing (dysphagia), and ipsilateral facial numbness or burning sensations2, 5.
  • Physical Examination & Named Clinical Signs:
    • Ipsilateral Signs: Horner syndrome (ptosis, miosis, anhidrosis), facial hypalgesia and thermoanesthesia, limb and gait ataxia (falling toward the side of the lesion), nystagmus, skew deviation, and impaired gag reflex2.
    • Contralateral Signs: Loss of pain and temperature sensation affecting the trunk and extremities, with preservation of tactile and vibratory modalities (dissociated sensory loss)1, 2.
    • Bulbar Involvement: Dysphonia, nasal regurgitation, and severe dysphagia stemming from nucleus ambiguus dysfunction (IX and X cranial nerves)2, 4.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationDiffusion-Weighted MRI (DWI) of the brain and posterior fossa demonstrating restricted diffusion in the posterolateral medulla; paired with CT or MR angiography displaying vertebral artery or PICA occlusion/dissection.
Laboratory PanelComprehensive baseline workup including complete blood count, lipid panel, HbA1c, renal and hepatic function panels, coagulation profile, and cardiac biomarkers to evaluate stroke etiology.
Imaging / Radiology (X-ray, US, CT, MRI)Non-contrast head CT is primarily utilized to rapidly exclude acute intracranial hemorrhage. Brain MRI (T2/FLAIR and DWI) provides definitive visualization of the medullary infarct, though early false-negative DWI in the posterior fossa can occur5. Vascular imaging (CTA/MRA) outlines vessel patency and dissection flaps.
ECG / Histopathology / Procedural12-lead ECG and telemetry monitoring to detect paroxysmal atrial fibrillation; echocardiography (transthoracic and transesophageal) to assess for cardioembolic sources; formal speech and swallowing evaluation (flexible endoscopic evaluation of swallowing or videofluoroscopy).

5. Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
National Institutes of Health Stroke Scale (NIHSS)Quantifies baseline neurological deficit. Brainstem strokes often present with deceptively low initial NIHSS scores despite profound functional impairment (e.g., severe dysphagia and vertigo without dense hemiparesis).
Dysphagia Severity Rating Scale (DSRS) / Functional Oral Intake Scale (FOIS)Evaluates swallowing safety and oral nutrition capacity. Dictates the duration of NPO status, enteral nutrition requirements (nasogastric or percutaneous endoscopic gastrostomy tube), and timing of swallow rehabilitation.
TOAST ClassificationCategorizes ischemic stroke subtype (Large-artery atherosclerosis, cardioembolism, small-vessel occlusion, other determined etiology, or undetermined etiology) to guide long-term secondary prevention.

6. Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Vestibular Neuritis / LabyrinthitisPresents with acute vertigo, nausea, and nystagmus, but lacks central brainstem signs such as Horner syndrome, crossed sensory deficits, palatal weakness, or ataxia. Head impulse test is typically abnormal in peripheral vestibulopathy.
Cerebellar Hemorrhage or InfarctionCan cause prominent ataxia, vertigo, and vomiting; however, mass effect on posterior fossa structures, altered mental status, and lack of dissociated sensory loss or classic cranial nerve-medullary pathway combinations help differentiate it on neuroimaging.
Multiple Sclerosis (Brainstem Plaque)Often presents in younger patients with subacute onset, positive oligoclonal bands in CSF, and demyelinating plaques on MRI that disseminate in space and time rather than conforming strictly to a vascular territory.
Wernicke EncephalopathyFeatures ophthalmoparesis, ataxia, and confusion, typically occurring in the setting of chronic thiamine deficiency (alcoholism, malnutrition). MRI demonstrates characteristic symmetrical signal changes in the periaqueductal gray and medial thalami.

7. Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Airway protection and hemodynamic stabilization. Continuous cardiac telemetry and pulse oximetry monitoring due to risk of respiratory depression or autonomic instability.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Acute Reperfusion: Intravenous thrombolysis with Alteplase (0.9 mg/kg IV, maximum 90 mg; 10% given as a bolus over 1 minute, remainder infused over 60 minutes) if patient presents within the 4.5-hour therapeutic window, or Tenecteplase (0.25 mg/kg IV single bolus, maximum 25 mg), provided no absolute contraindications exist.
    • Secondary Stroke Prevention: Antiplatelet therapy initiated after excluding hemorrhage (e.g., Aspirin 81–325 mg PO daily, or dual antiplatelet therapy with Aspirin and Clopidogrel short-term for high-risk minor stroke/TIA). High-intensity statin therapy (e.g., Atorvastatin 80 mg PO daily). Strict blood pressure management. If cardioembolic etiology is identified, transition to long-term oral anticoagulation (DOACs or warfarin).
  • Surgical / Interventional Indications: Endovascular thrombectomy (EVT) for large vessel occlusions of the vertebral artery in select cases. Surgical decompression or ventriculostomy for posterior fossa edema causing brainstem compression or obstructive hydrocephalus. Placement of a percutaneous endoscopic gastrostomy (PEG) tube for patients with prolonged dysphagia.

8. Complications & Prognosis

  • Aspiration Pneumonia: High risk due to severe pharyngeal weakness, palatal palsy, and impaired laryngeal elevation; managed via strict NPO status, early speech therapy assessment, and enteral feeding tubes when necessary7.
  • Central Hypoventilation & Autonomic Instability: Damage to respiratory centers can precipitate respiratory failure and erratic blood pressure regulation requiring intensive care unit monitoring.
  • Chronic Sensory Deficits & Neurotrophic Keratopathy: Persistent neuropathic facial pain, gait ataxia, and potential corneal anesthesia leading to epithelial breakdown and ulceration due to trigeminal nerve involvement3.
  • Prognosis: Overall long-term survival is generally favorable compared to anterior circulation strokes, and many patients achieve independent ambulation over time, though chronic dysphagia, balance deficits, and neuropathic pain frequently result in long-term morbidity.